Severe or progressive kidney disease or dysfunction (possible exception: nephrosis)
Severe hepatic disease
Pre-existing elevated serum potassium, or hyperkalemia developing on the drug
Dietary potassium supplements, potassium salts, or potassium-containing salt substitutes
Other potassium-sparing agents (spironolactone, amiloride, other triamterene-containing formulations) — deaths reported with concomitant spironolactone
Cautions
Hyperkalemia (K+ >=5.5 mEq/L) can occur and may be fatal if uncorrected — monitor potassium frequently; obtain ECG if hyperkalemia suspected
Elevates uric acid (gout predisposition); caution with history of renal stones (triamterene found in stones)
Adverse reactions
Hyperkalemia
Hypokalemia
Azotemia / elevated BUN and creatinine
Renal stones
Acute interstitial nephritis (rare)
Acute renal failure (one irreversible case)
Jaundice / liver enzyme abnormalities
Nausea/vomiting
Diarrhea
Thrombocytopenia
Megaloblastic anemia
Weakness/fatigue
Dizziness
Headache
Dry mouth
Anaphylaxis
Rash
Photosensitivity
Pregnancy No fetal harm in rat studies up to 20x MRHD; crosses placenta into cord blood; use only if clearly needed — routine diuretic use in healthy pregnant women is inappropriate